152 related articles for article (PubMed ID: 1710548)
1. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
Ohlin M; Sundqvist VA; Gilljam G; Rudén U; Gombert FO; Wahren B; Borrebaeck CA
Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of mouse monoclonal antibodies to the ppUL83 lower matrix phosphoprotein of human cytomegalovirus.
Zal B; Booth J; Chadwick J; Baboonian C
J Med Virol; 1999 Mar; 57(3):290-7. PubMed ID: 10022802
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells.
Larose Y; Tackaberry ES; Brodeur BR
Hum Antibodies Hybridomas; 1991 Apr; 2(2):67-73. PubMed ID: 1714785
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping.
Ohlin M; Broliden PA; Danielsson L; Wahren B; Rosen J; Jondal M; Borrebaeck CA
Immunology; 1989 Nov; 68(3):325-31. PubMed ID: 2480328
[TBL] [Abstract][Full Text] [Related]
6. A human monoclonal antibody to cytomegalovirus (CMV).
Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U
J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies to viral peptides.
Sidorova E; Borisova T; Lyakisheva L; Rosen A
Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
[TBL] [Abstract][Full Text] [Related]
8. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
9. [Conserved amino-acid residue mutations in epitope of human cytomegalovirus antigen M].
Wang B; Liu Z; Liu Y; Shen B; Liu C; Shao N
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1128-32. PubMed ID: 18837384
[TBL] [Abstract][Full Text] [Related]
10. Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system.
Charpentier B; Michelson S; Martin B
J Immunol; 1986 Jul; 137(1):330-6. PubMed ID: 2423608
[TBL] [Abstract][Full Text] [Related]
11. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.
Kern F; Bunde T; Faulhaber N; Kiecker F; Khatamzas E; Rudawski IM; Pruss A; Gratama JW; Volkmer-Engert R; Ewert R; Reinke P; Volk HD; Picker LJ
J Infect Dis; 2002 Jun; 185(12):1709-16. PubMed ID: 12085315
[TBL] [Abstract][Full Text] [Related]
13. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
14. Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide pool.
Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Bracci L; Lozzi L; Scarso L; Tripodi G; Manca F
Hum Immunol; 2004 May; 65(5):537-43. PubMed ID: 15172454
[TBL] [Abstract][Full Text] [Related]
15. Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
Chin LT; Hinkula J; Levi M; Ohlin M; Wahren B; Borrebaeck CA
Immunology; 1994 Mar; 81(3):428-34. PubMed ID: 7515847
[TBL] [Abstract][Full Text] [Related]
16. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells.
Steenbakkers PG; Van Wezenbeek PM; van Zanten J; The TH
Hum Antibodies Hybridomas; 1993 Oct; 4(4):166-73. PubMed ID: 7504956
[TBL] [Abstract][Full Text] [Related]
17. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
[TBL] [Abstract][Full Text] [Related]
18. The reactions of monoclonal antibodies with structural proteins of mumps virus.
Orvell C
J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
[TBL] [Abstract][Full Text] [Related]
19. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.
Lacey SF; Martinez J; Gallez-Hawkins G; Thao L; Longmate J; Haq W; Spielberger R; Forman SJ; Zaia JA; Diamond DJ
J Infect Dis; 2005 Mar; 191(6):977-84. PubMed ID: 15717275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
